296 related articles for article (PubMed ID: 22277163)
21. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome.
Gulcelik NE; Aral Y; Serter R; Demir Y; Culha C
Gynecol Endocrinol; 2006 Sep; 22(9):511-5. PubMed ID: 17071536
[TBL] [Abstract][Full Text] [Related]
22. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
23. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
24. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
26. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
Li X; Li X; Huang HY; Ma D; Zhu MW; Lin JF
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2607-10. PubMed ID: 20137676
[TBL] [Abstract][Full Text] [Related]
27. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.
Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska B
Gynecol Endocrinol; 2007 Jun; 23(6):325-31. PubMed ID: 17616856
[TBL] [Abstract][Full Text] [Related]
28. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome.
Shorakae S; Abell SK; Hiam DS; Lambert EA; Eikelis N; Jona E; Sari CI; Stepto NK; Lambert GW; de Courten B; Teede HJ
Fertil Steril; 2018 Mar; 109(3):532-539. PubMed ID: 29428305
[TBL] [Abstract][Full Text] [Related]
29. CAG repeat polymorphism of androgen receptor gene and X-chromosome inactivation in daughters of women with polycystic ovary syndrome (PCOS): relationship with endocrine and metabolic parameters.
Echiburú B; Pérez-Bravo F; Maliqueo M; Ladrón de Guevara A; Gálvez C; Crisosto N; Sir-Petermann T
Gynecol Endocrinol; 2012 Jul; 28(7):516-20. PubMed ID: 22724574
[TBL] [Abstract][Full Text] [Related]
30. Serum resistin and adiponectin levels in women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Demirci H; Oztürk C; Kan E; Ayvaz G; Arslan M
Gynecol Endocrinol; 2009 Apr; 25(4):246-52. PubMed ID: 19408174
[TBL] [Abstract][Full Text] [Related]
31. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome.
Wang Q; Guo T; Tao Y; Wang Q; Song Y; Huang W
Gynecol Endocrinol; 2011 Nov; 27(11):931-4. PubMed ID: 21495802
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
[TBL] [Abstract][Full Text] [Related]
33. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women.
Zeman M; Jirak R; Jachymova M; Vecka M; Tvrzicka E; Zak A
Neuro Endocrinol Lett; 2009; 30(3):387-95. PubMed ID: 19855365
[TBL] [Abstract][Full Text] [Related]
34. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
35. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
Roemmich JN; Clark PA; Lusk M; Friel A; Weltman A; Epstein LH; Rogol AD
Int J Obes Relat Metab Disord; 2002 May; 26(5):701-9. PubMed ID: 12032756
[TBL] [Abstract][Full Text] [Related]
36. Adiposity, chronic inflammation, and the prepubertal decline of sex hormone binding globulin in children: evidence for associations with the timing of puberty (Earlybird 58).
Pinkney J; Streeter A; Hosking J; Mostazir M; Jeffery A; Wilkin T
J Clin Endocrinol Metab; 2014 Sep; 99(9):3224-32. PubMed ID: 24926948
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
38. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.
Maliqueo M; Sir-Petermann T; Pérez V; Echiburú B; de Guevara AL; Gálvez C; Crisosto N; Azziz R
J Clin Endocrinol Metab; 2009 Sep; 94(9):3282-8. PubMed ID: 19567527
[TBL] [Abstract][Full Text] [Related]
39. [Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance].
Calvar CE; Intebi AD; Bengolea SV; Hermes R; Spinedi E
Medicina (B Aires); 2003; 63(6):704-10. PubMed ID: 14719312
[TBL] [Abstract][Full Text] [Related]
40. Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin.
Unanue N; Bazaes R; Iñiguez G; Cortés F; Avila A; Mericq V
Horm Res; 2007; 67(3):152-8. PubMed ID: 17085944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
